Clinical Trial

Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will evaluate the subjective and behavioral effects of cannabis products labeled as indica, sativa, or generic.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-10-03; most recent amendment 2026-05-21.
Trial Details
NCT Number NCT07214155
Lead Sponsor Johns Hopkins University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Cannabis Intoxication
Enrollment 70 participants
Start Date 2026-09-15
Primary Completion 2029-06 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-05